Edition:
India

Sensus Healthcare Inc (SRTS.OQ)

SRTS.OQ on NASDAQ Stock Exchange Capital Market

5.96USD
12:35am IST
Change (% chg)

$-0.27 (-4.33%)
Prev Close
$6.23
Open
$6.20
Day's High
$6.20
Day's Low
$5.70
Volume
40,934
Avg. Vol
16,498
52-wk High
$8.80
52-wk Low
$4.91

Latest Key Developments (Source: Significant Developments)

Sensus Healthcare Reports Q3 Loss Per Share $0.03
Friday, 2 Nov 2018 

Nov 1 (Reuters) - Sensus Healthcare Inc ::Q3 LOSS PER SHARE $0.03.Q3 EARNINGS PER SHARE VIEW $-0.07 -- THOMSON REUTERS I/B/E/S.Q3 REVENUE $6.3 MILLION VERSUS I/B/E/S VIEW $5.8 MILLION.CASH AND CASH EQUIVALENTS WERE $17.1 MILLION AS OF SEPT 30, 2018.  Full Article

Sensus Healthcare Expands International Business To Meet Rising Patient Demand For Non-Invasive Skin Cancer And Keloid Treatments
Thursday, 19 Apr 2018 

April 19 (Reuters) - Sensus Healthcare Inc ::SENSUS HEALTHCARE EXPANDS INTERNATIONAL BUSINESS TO MEET RISING PATIENT DEMAND FOR NON-INVASIVE SKIN CANCER AND KELOID TREATMENTS.SENSUS HEALTHCARE - "SIGNIFICANTLY EXPANDING" GLOBAL BUSINESS WITH SRT TO MEET CONSUMER DEMAND FOR NON-INVASIVE, SKIN CANCER AND KELOID TREATMENTS.  Full Article

Sensus Healthcare files for mixed shelf of up to $20 mln - SEC filing
Tuesday, 7 Nov 2017 

Nov 6 (Reuters) - Sensus Healthcare Inc :Sensus Healthcare Inc files for mixed shelf of up to $20 million - SEC filing.  Full Article

Sensus Healthcare reports Q3 loss per share of $0.07
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Sensus Healthcare Inc :Sensus Healthcare reports third quarter financial results featuring revenue up 44 percent.Q3 loss per share $0.07.Q3 revenue rose 44 percent to $4.8 million.  Full Article

Sensus Healthcare launches SRT-100 in China for Keloid treatment
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Sensus Healthcare Inc :Sensus Healthcare Inc - ‍has launched SRT-100 in China for treatment and prevention of Keloids with Chindex Medical Limited​.Sensus Healthcare- ‍extension of exclusive distribution deal with Chindex Medical, a JV between Fosun Pharma and Chindex International, through 2020​.  Full Article

Sensus Healthcare says SRT-100 now cleared for sale in Mexico​
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Sensus Healthcare Inc -:Sensus Healthcare Inc - ‍announces that SRT-100 is now cleared for sale in Mexico​.Sensus Healthcare Inc - ‍Sensus has engaged Cyber Robotics of Mexico City as its distribution partner​.  Full Article

Sensus Healthcare Q2 loss per share $0.06
Friday, 4 Aug 2017 

Aug 3 (Reuters) - Sensus Healthcare Inc :Sensus Healthcare reports record second quarter financial results.Q2 loss per share $0.06.Q2 revenue rose 39 percent to $5.0 million.  Full Article

Sensus Healthcare receives approval to sell SRT-100 in China
Wednesday, 26 Jul 2017 

July 26 (Reuters) - Sensus Healthcare Inc :Sensus Healthcare receives regulatory approval to sell the SRT-100 in China for the treatment and prevention of keloids.Sensus Healthcare Inc says Chindex Medical plans to launch SRT-100 for treatment of keloids into market during Q4 of 2017.Sensus Healthcare Inc - ‍SRT-100 has been cleared by China Food and Drug Administration to treat and prevent keloids​.  Full Article

Sensus Healthcare Q1 revenue rose 43.5 percent to $4.4 million
Friday, 5 May 2017 

May 4 (Reuters) - Sensus Healthcare Inc :Sensus Healthcare Inc - Cash, cash equivalents and investments were $11.0 million as of March 31, 2017..Q1 loss per share $0.12.Q1 revenue rose 43.5 percent to $4.4 million.  Full Article

Sensus Healthcare reports Q4 results
Friday, 3 Feb 2017 

Sensus Healthcare Inc : Sensus Healthcare Inc - sold 19 systems in q4 and a total of 59 systems in 2016, increasing worldwide installed base to 271 units as of Dec 31, 2016 . Sensus Healthcare Inc - revenues for q4 2016 increased 27 pct to $4.88 million, compared to $3.84 million for q4 2015 . Sensus Healthcare reports fourth quarter and full year 2016 results .Q4 gaap earnings per share $0.00.  Full Article